We are a precision genetic medicine company dedicated to our mission of developing gene therapies with the potential to restore, improve, and preserve high-acuity physiologic hearing for people worldwide who live with disabling hearing loss. We have built a precision genetic medicine platform that incorporates a proprietary vector library consisting of variants of a small virus commonly used in gene therapy, known as adeno-associated virus, or AAV, and a novel delivery approach. We were formed as a limited liability corporation under the laws of the Commonwealth of Massachusetts on March 7, 2016 under the name Akouos, LLC. We converted into a corporation under the laws of the State of Delaware on November 23, 2016 under the name Akouos, Inc. Our principal executive offices are located at 645 Summer Street, Suite 200, Boston, Massachusetts 02210 and our telephone number is (857) 410-1818. Our website address is www.akouos.com.

Akouos, Inc.

Akouos, Inc. operates as a biotechnology company. The Company develops targeted therapies to restore and preserve hearing in genetically-defined patient populations. Akouos serves customers in the State of Massachusetts

Should you buy, sell, or hold Akouos, Inc. (AKUS) ?

Akouos, Inc. (AKUS) : Buy or Sell